Alanine to serine polymorphism at position 986 of the calcium-sensing receptor associated with coronary heart disease, myocardial infarction, all-cause, and cardiovascular mortality

Journal of Clinical Endocrinology and Metabolism

Volumn 92, Issue 6, 2007, Pages 2363-2369

  März, Winfried ^a   Seelhorst, Ursula ^b   Wellnitz, Britta ^b   Tiran, Beate ^c   Obermayer Pietsch, Barbara ^c   Renner, Wilfried ^c   Boehm, Bernhard O ^d   Ritz, Eberhard ^e   Hoffmann, Michael M ^f  

^a SYNLAB ACADEMY   (Germany)

^b Ludwigshafen Risk and Cardiovascular Health Study Nonprofit LLC   (Germany)

^c MEDICAL UNIVERSITY OF GRAZ   (Austria)

^d UNIVERSITY HOSPITAL ULM   (Germany)

^e UNIVERSITY OF HEIDELBERG   (Germany)

^f UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; CALCIUM; CALCIUM SENSING RECEPTOR; PHOSPHATE; SERINE;

ADULT; AGED; ALLELE; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; HEART INFARCTION; HOMOZYGOSITY; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREVALENCE; PRIORITY JOURNAL;

EID: 34347237294     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2006-0071     Document Type: Article

References (57)

1. Wong ND, Hsu JC, Detrano RC, Diamond G, Eisenberg H, Gardin JM 2000 Coronary artery calcium evaluation by electron beam computed tomography and its relation to new cardiovascular events. Am J Cardiol 86:495-498
2. Wilson PW, Kauppila LI, O'Donnell CJ, Kiel DP, Hannan M, Polak JM, Cupples LA 2001 Abdominal aortic calcific deposits are an important predictor of vascular morbidity and mortality. Circulation 103:1529-1534
3. Hedback G, Oden A 1998 Death risk factor analysis in primary hyperparathyroidism. Eur J Clin Invest 28:1011-1018
4. Schulz E, Arfai K, Liu X, Sayre J, Gilsanz V 2004 Aortic calcification and the risk of osteoporosis and fractures. J Clin Endocrinol Metab 89:4246-4253
5. Browner WS, Pressman AR, Nevitt MC, Cauley JA, Cummings SR 1993 Association between low bone density and stroke in elderly women. The study of osteoporotic fractures. Stroke 24:940-946
6. Banks LM, Lees B, MacSweeney JE, Stevenson JC 1994 Effect of degenerative spinal and aortic calcification on bone density measurements in post-menopausal women: links between osteoporosis and cardiovascular disease? Eur J Clin Invest 24:813-817
7. Jie KG, Bots ML, Vermeer C, Witteman JC, Grobbee DE 1996 Vitamin K status and bone mass in women with and without aortic atherosclerosis: a population-based study. Calcif Tissue Int 59:352-356
8. Hak AE, Pols HA, van Hemert AM, Hofman A, Witteman JC 2000 Progression of aortic calcification is associated with metacarpal bone loss during menopause: a population-based longitudinal study. Arterioscler Thromb Vasc Biol 20:1926-1931
9. Brown EM, Pollak M, Hebert SC 1998 The extracellular calcium-sensing receptor: its role in health and disease. Annu Rev Med 49:15-29
10. Pearce SH 2002 Clinical disorders of extracellular calcium-sensing and the molecular biology of the calcium-sensing receptor. Ann Med 34:201-206
11. Brown EM 1999 Physiology and pathophysiology of the extracellular calciumsensing receptor. Am J Med 106:238-253
12. Yamaguchi T, Chattopadhyay N, Brown EM 2000 G protein-coupled extracellular Ca2+ (Ca2+o)-sensing receptor (CaR): roles in cell signaling and control of diverse cellular functions. Adv Pharmacol 47:209-253
13. Rose B, Shoback D 2001 Update of the calcium-sensing receptor and calcimimetics. Curr Opin Endocrinol Diabetes 8:29-33
14. Coburn JW, Elangovan L, Goodman WG, Frazao JM 1999 Calcium-sensing receptor and calcimimetic agents. Kidney Int Suppl 73:S52-S58
15. Watanabe S, Fukumoto S, Chang H, Takeuchi Y, Hasegawa Y, Okazaki R, Chikatsu N, Fujita T 2002 Association between activating mutations of calcium-sensing receptor and Bartter's syndrome. Lancet 360:692-694
16. Spurr NK 2003 Genetics of calcium-sensing-regulation of calcium levels in the body. Curr Opin Pharmacol 3:291-294
17. Pearce SH, Thakker RV 1997 The calcium-sensing receptor: insights into extracellular calcium homeostasis in health and disease. J Endocrinol 154:371-378
18. Heath III H, Odelberg S, Jackson CE, Teh BT, Hayward N, Larsson C, Buist NR, Krapcho KJ, Hung BC, Capuano IV, Garrett JE, Leppert MF 1996 Clustered inactivating mutations and benign polymorphisms of the calcium receptor gene in familial benign hypocalciuric hypercalcemia suggest receptor functional domains. J Clin Endocrinol Metab 81:1312-1317
19. Cole DE, Peltekova VD, Rubin LA, Hawker GA, Vieth R, Liew CC, Hwang DM, Evrovski J, Hendy GN 1999 A986S polymorphism of the calcium-sensing receptor and circulating calcium concentrations. Lancet 353:112-115
20. Cole DE, Vieth R, Trang HM, Wong BY, Hendy GN, Rubin LA 2001 Association between total serum calcium and the A986S polymorphism of the calcium-sensing receptor gene. Mol Genet Metab 72:168-174
21. Lorentzon M, Lorentzon R, Lerner UH, Nordstrom P 2001 Calcium sensing receptor gene polymorphism, circulating calcium concentrations and bone mineral density in healthy adolescent girls. Eur J Endocrinol 144:257-261
22. Young R, Wu F, Van de Water N, Ames R, Gamble G, Reid IR 2003 Calcium sensing receptor gene A986S polymorphism and responsiveness to calcium supplementation in postmenopausal women. J Clin Endocrinol Metab 88:697-700
23. Takacs I, Speer G, Bajnok E, Tabak A, Nagy Z, Horvath C, Kovacs K, Lakatos P 2002 Lack of association between calcium-sensing receptor gene "A986S" polymorphism and bone mineral density in Hungarian postmenopausal women. Bone 30:849-852
24. Cetani F, Pardi E, Borsari S, Vignali E, Dipollina G, Braga V, Adami S, Pinchera A, Marcocci C 2003 Calcium-sensing receptor gene polymorphism is not associated with bone mineral density in Italian postmenopausal women. Eur J Endocrinol 148:603-607
25. Winkelmann BR, März W, Boehm BO, Zotz R, Hager J, Hellstern P, Senges J 2001 Rationale and design of the LURIC study-a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease. Pharmacogenomics 2:S1-S73
26. Austen WG, Edwards JE, Frye RL, Gensini CG, Gott VL, Griffith LSC, McGoon DC, Murphy MC, Roe BB 1975 A reporting system on patients evaluated for coronary artery disease. Report of the ad hoc committee for grading of coronary artery disease. Circulation 50:7-40
27. American Diabetes Association 2006 Diagnosis and classification of diabetes mellitus. Diabetes Care 29(Suppl 1):S43-S48
28. Wanner C, Hörl WH, Luley C, Wieland H 1991 Effects of HMG-CoA reductase inhibitors in hypercholesterolemic patients on hemodialysis. Kidney Int 31: 754-760
29. Cockcroft DW, Gault MH 1976 Prediction of creatinine clearance from serum creatinine. Nephron 16:31-41
30. Cannon CP, Braunwald E, McCabe CH, Rader DJ, Rouleau JL, Belder R, Joyal SV, Hill KA, Pfeffer MA, Skene AM 2004 Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 350:1495-1504
31. Fox KM 2003 Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet 362:782-788
32. Narang R, Ridout D, Nonis C, Kooner JS 1997 Serum calcium, phosphorus and albumin levels in relation to the angiographic severity of coronary artery disease. Int J Cardiol 60:73-79
33. Al-Delaimy WK, Rimm E, Willett WC, Stampfer MJ, Hu FB 2003 A prospective study of calcium intake from diet and supplements and risk of ischemic heart disease among men. Am J Clin Nutr 77:814-818
34. Procopio M, Magro G, Cesario F, Piovesan A, Pia A, Molineri N, Borretta G 2002 The oral glucose tolerance test reveals a high frequency of both impaired glucose tolerance and undiagnosed Type 2 diabetes mellitus in primary hyperparathyroidism. Diabet Med 19:958-961
35. Taylor WH, Khaleeli AA 1997 Prevalence of primary hyperparathyroidism in patients with diabetes mellitus. Diabet Med 14:386-389
36. DeFronzo RA, Lang R 1980 Hypophosphatemia and glucose intolerance: evidence for tissue insensitivity to insulin. N Engl J Med 303:1259-1263
37. Richards ML, Thompson NW 1999 Diabetes mellitus with hyperparathyroidism: another indication for parathyroidectomy? Surgery 126:1160-1166
38. Hagstrom E, Lundgren E, Lithell H, Berglund L, Ljunghall S, Hellman P, Rastad J 2002 Normalized dyslipidaemia after parathyroidectomy in mild primary hyperparathyroidism: population-based study over five years. Clin Endocrinol (Oxf) 56:253-260
39. Akmal M, Massry SG, Goldstein DA, Fanti P, Weisz A, DeFronzo RA 1985 Role of parathyroid hormone in the glucose intolerance of chronic renal failure. J Clin Invest 75:1037-1044
40. Akmal M, Kasim SE, Soliman AR, Massry SG 1990 Excess parathyroid hormone adversely affects lipid metabolism in chronic renal failure. Kidney Int 37:854-858
41. Throckmorton D, Kurscheid-Reich D, Rosales OR, Rodriguez-Commes J, Lopez R, Sumpio B, Zhong Q, Ding KH, McCarthy R, Barrett PQ, Isales CM 2002 Parathyroid hormone effects on signaling pathways in endothelial cells vary with peptide concentration. Peptides 23:79-85
42. Jiang B, Morimoto S, Yang J, Niinoabu T, Fukuo K, Ogihara T 1998 Expression of parathyroid hormone/parathyroid hormone-related protein receptor in vascular endothelial cells. J Cardiovasc Pharmacol 31(Suppl 1):S142-S144
43. Schulze MR, Mugge A, Harms HM, Cremer J, Frombach R, Lichtlen PR 1993 Human parathyroid hormone dilates both pig coronary and human inferior epigastric arteries by a cyclic AMP-dependent pathway. Artery 20:147-162
44. Stefenelli T, Abela C, Frank H, Koller-Strametz J, Globits S, Bergler-Klein J, Niederle B 1997 Cardiac abnormalities in patients with primary hyperparathyroidism: implications for follow-up. J Clin Endocrinol Metab 82:106-112
45. Piovesan A, Molineri N, Casasso F, Emmolo I, Ugliengo G, Cesario F, Borretta G 1999 Left ventricular hypertrophy in primary hyperparathyroidism. Effects of successful parathyroidectomy. Clin Endocrinol (Oxf) 50:321-328
46. Hedback G, Oden A 1998 Increased risk of death from primary hyperparathyroidism - an update. Eur J Clin Invest 28:271-276
47. Schluter KD, Piper HM 1998 Cardiovascular actions of parathyroid hormone and parathyroid hormone-related peptide. Cardiovasc Res 37:34-41
48. Baczynski R, Massry SG, Kohan R, Magott M, Saglikes Y, Brautbar N 1985 Effect of parathyroid hormone on myocardial energy metabolism in the rat. Kidney Int 27:718-725
49. Bogin E, Levi J, Harary I, Massry SG 1982 Effects of parathyroid hormone on oxidative phosphorylation of heart mitochondria. Miner Electrolyte Metab 7:151-156
50. Amann K, Ritz E, Wiest G, Klaus G, Mall G 1994 A role of parathyroid hormone for the activation of cardiac fibroblasts in uremia. J Am Soc Nephrol 4:1814-1819
51. Amann K, Tornig J, Flechtenmacher C, Nabokov A, Mall G, Ritz E 1995 Blood-pressure-independent wall thickening of intramyocardial arterioles in experimental uraemia: evidence for a permissive action of PTH. Nephrol Dial Transplant 10:2043-2048
52. Tuzcu EM, Kapadia SR, Tutar E, Ziada KM, Hobbs RE, McCarthy PM, Young JB, Nissen SE 2001 High prevalence of coronary atherosclerosis in asymptomatic teenagers and young adults: evidence from intravascular ultrasound. Circulation 103:2705-2710
53. Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense HW, Joffres M, Kastarinen M, Poulter N, Primatesta P, Rodriguez-Artalejo F, Stegmayr B, Thamm M, Tuomilehto J, Vanuzzo D, Vescio F 2003 Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 289:2363-2369
54. Hauner H, Koster I, von Ferber L 2003 [Prevalence of diabetes mellitus in Germany 1998-2001. Secondary data analysis of a health insurance sample of the AOK in Hessen/KV in Hessen]. Dtsch Med Wochenschr 128:2632-2637 (German)
55. Taubert G, Winkelmann BR, Schleiffer T, Marz W, Winkler R, Gok R, Klein B, Schneider S, Boehm BO 2003 Prevalence, predictors, and consequences of unrecognized diabetes mellitus in 3266 patients scheduled for coronary angiography. Am Heart J 145:285-291
56. Centers for Disease Control and Prevention (CDC) 2003 Prevalence of diabetes and impaired fasting glucose in adults - United States, 1999-2000. MMWR Morb Mortal Wkly Rep 52:833-837
57. Hegele RA 2002 SNP judgments and freedom of association. Arterioscler Thromb Vasc Biol 22:1058-1061